Skip to main content

Table 1 Characteristics of the study population at baseline

From: Dysregulation of iron homeostasis in airways associated with persistent preschool wheezing

Characteristic

Control,

N = 56

Resolution of wheezing,

N = 36

Persistence of wheezing,

N = 48

P value*

P value†

Sex (% male)

29 (51.8)

24 (66.7)

28 (58.3)

0.36

0.44

Age (month), median (IQR)

2.29 (1.2, 4.2)

3.39 (1.8, 4.5)

2.92 (1.6, 4.2)

0.70

1.00

Preterm (%)

4 (7.1)

6 (16.7)

8 (16.7)

0.13

1.00

Cesarian section (%)

20 (64.3)

19 (52.8)

23 (47.9)

0.14

0.66

Breastfeeding time (month), median (IQR)

8.0 (6.0, 12.0)

9.5 (6.0, 12.0)

6.0 (5.8, 10.0)

0.14

0.008

Family history of asthma (%)

5 (8.9)

7 (19.4)

16 (33.3)

0.004

0.16

Allergic rhinitis (%)

12 (21.4)

19 (52.8)

35 (72.9)

 < 0.001

0.057

History of eczema (%)

22 (39.3)

19 (52.8)

29 (60.4)

0.035

0.48

Allergy history (%)

7 (12.5)

9 (25.0)

10 (20.8)

0.080

0.65

Prenatal smoking (%)

11 (20)

17 (47)

21 (44.8)

0.004

0.75

Pet ownership (%)

4 (7.1)

1 (2.8)

4 (8.3)

0.73

0.39

First wheezing episode age (month), median (IQR)

 − 

10 (4.0, 24.0)

8 (4.5, 13.5)

 − 

0.67

Past wheezing episodes ≥ 5 (%)

 − 

16 (44%)

34 (71%)

 − 

0.015

Phenotype of wheezing (% EVW)

 − 

23 (63.9)

29 (60.4)

 − 

0.75

Positive mAPI (%)

 − 

7 (19.4)

26 (54.2)

 − 

0.001

mAPI major criteria (%)

     

 Parental asthma

2 (3.6)

5 (13.9)

5 (10.4)

0.13

0.74

 Atopic dermatitis

1 (1.8)

4 (11.1)

4 (8.3)

0.15

0.72

 Aeroallergens allergy

 − 

11 (30.6)

26 (54.2)

 − 

0.031

mAPI minor criteria (%)

     

 Wheezing without colds

 − 

13 (36.1)

19 (39.6)

 − 

0.75

 Food allergy

 − 

11 (30.6)

18 (37.5)

 − 

0.51

 Eosinophilia (≥ 4%)

4 (7.1)

7 (19.4)

15 (31.2)

0.005

0.22

  1. P values of statistical difference between groups using either Wilcoxon rank sum test, Pearson's chi-squared test or continuous correction chi-square test depending on the characteristics of the data
  2. EVW episodic viral wheezing, IQR interquartile range, mAPI modified Asthma Predictive Index
  3. *P values for all patients with recurrent wheezing (included five patients who were lost to follow-up) versus controls
  4. †P values for recurrent wheezers experienced persistent wheezing versus those patients without persistent wheezing